Finch Therapeutics Group, Inc. (FNCH)
OTCMKTS
· Delayed Price · Currency is USD
14.10
0.00 (0.00%)
Feb 19, 2025, 9:45 AM EST
Finch Therapeutics Group Revenue
In the year 2023, Finch Therapeutics Group had annual revenue of $107.00K, down -87.57%.
Revenue
107.00K
Revenue Growth
-87.57%
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
1
Market Cap
23.28M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 107.00K | -754.00K | -87.57% |
Dec 31, 2022 | 861.00K | -17.67M | -95.35% |
Dec 31, 2021 | 18.53M | 10.81M | 140.08% |
Dec 31, 2020 | 7.72M | -2.44M | -23.98% |
Dec 31, 2019 | 10.15M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Endo Inc. | 1.79B |
SS Innovations International | 16.04M |
Veradigm | 1.53B |
Elite Pharmaceuticals | 70.00M |
Glass House Brands | 188.29M |
Northwest Biotherapeutics | 1.60M |
BioStem Technologies | 210.49M |
Silence Therapeutics | 21.77M |
Finch Therapeutics Group News
- 13 days ago - Finch Therapeutics: Post-Trial Decision Can Potentially Drive Shares To Trade Higher - Seeking Alpha
- 4 months ago - Finch Therapeutics looks to delist from the Nasdaq Global Select Market - Seeking Alpha
- 4 months ago - Finch Announces Delisting from Nasdaq and SEC Deregistration - GlobeNewsWire
- 1 year ago - Finch Announces Reverse Stock Split of Common Stock - GlobeNewsWire
- 1 year ago - Finch Therapeutics Reports First Quarter 2023 Financial Results and Provides Business Updates - GlobeNewsWire
- 2 years ago - Finch Therapeutics Announces Clinical Collaboration in Ulcerative Colitis with Brigham and Women's Hospital and Updates to University of Minnesota License Agreement - GlobeNewsWire
- 2 years ago - Finch Therapeutics: Why This Finch Could Fly - An Asymmetric Risk/Reward Opportunity - Seeking Alpha
- 2 years ago - Finch Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Updates - GlobeNewsWire